Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JW PharmaceuticalXKRX:001060 +1.23%90 OCF Yield % is 12.81 as of Aug. 18, 2026, which is 60% above its 10-year median of 8.02. GuruFocus rates XKRX:001060 with a GF Score™ of 90/100 and a GF Value™ of ₩32,148.31 (Modestly Undervalued). Among 1,004 Drug Manufacturers companies, JW Pharmaceutical ranks better than 86.06% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for JW Pharmaceutical's OCF Yield % or its related term are showing as below:
XKRX:001060'
s OCF Yield % Range Over the Past 10 Years
Min: 0.58 Med: 8.02 Max: 18.5
Current: 12.81
During the past 13 years, the highest OCF Yield % of JW Pharmaceutical was 18.50%. The lowest was 0.58%. And the median was 8.02%.
XKRX:001060's OCF Yield % is ranked better than 86.06% of 1004
companies
in the Drug Manufacturers industry
Industry Median: 3.38
vs XKRX:001060: 12.81
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
JW Pharmaceutical OCF Yield % Related Terms
JW Pharmaceutical OCF Yield % Historical Data
* Premium members only.
The historical data trend for JW Pharmaceutical's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JW Pharmaceutical OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's OCF Yield % distribution charts can be found below:
* The bar in red indicates where JW Pharmaceutical's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JW Pharmaceutical (XKRX:001060) has a OCF Yield % of 12.81 as of Aug. 18, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on JW Pharmaceutical and its competitors. This is 60% above median its historical median of 8.02. Over the past decade, JW Pharmaceutical's OCF Yield % has ranged from 0.58 to 18.50. According to the industry distribution chart, JW Pharmaceutical ranks #140 out of 1004 companies in the Drug Manufacturers industry, placing it in the top 13.9%.
Is JW Pharmaceutical's OCF Yield % too high?
JW Pharmaceutical's current OCF Yield % of 12.81 is 60% above median its 10-year median of 8.02. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 18.50. The Drug Manufacturers industry median OCF Yield % is 3.38. JW Pharmaceutical's value of 12.81 is 279% above this industry median. Based on the distribution chart, JW Pharmaceutical ranks #140 out of 1004 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, JW Pharmaceutical has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JW Pharmaceutical's OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, JW Pharmaceutical ranks #140 out of 1004 companies for OCF Yield %. This places JW Pharmaceutical in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.38. JW Pharmaceutical's value of 12.81 is 279% above this benchmark. Historically, JW Pharmaceutical's own OCF Yield % has ranged from 0.58 to 18.50 over the past decade. While the company's 10-year median is 8.02 vs. the industry median of 3.38, JW Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.38, based on 1,004 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JW Pharmaceutical's current OCF Yield % of 12.81 is 279% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on JW Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JW Pharmaceutical's current OCF Yield % is 12.81, which is 60% above median its own 10-year median of 8.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JW Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, JW Pharmaceutical (XKRX:001060) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩32,148.31, compared to a current price of ₩28,850.00 — trading 10.3% below its estimated fair value. The current OCF Yield % is 12.81, which is 60% above median its 10-year median of 8.02 and 279% above the Drug Manufacturers industry median of 3.38. JW Pharmaceutical's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For JW Pharmaceutical (XKRX:001060), the current OCF Yield % is 12.81 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JW Pharmaceutical (XKRX:001060) Overvalued in 2026?
Based on GuruFocus' analysis, JW Pharmaceutical stock appears to be undervalued.
The current stock price of ₩28,850.00 is trading 10.3% below its estimated GF Value™ of ₩32,148.31.
GuruFocus considers JW Pharmaceutical to be Modestly Undervalued.
Key valuation signals for XKRX:001060:
OCF Yield %: 12.81 (60% above median its 10-year median of 8.02)
GF Value™: ₩32,148.31 vs. price of ₩28,850.00 (10.3% below fair value)
Industry Position: 279% above the Drug Manufacturers median (#140 of 1004)
No single metric tells the full story. See the XKRX:001060 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
90GF Score
Get the complete analysis for XKRX:001060
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:001060 has been successfully added to your 
